- Home
- PAHC vs BLFS Comparison
PAHC vs BLFS Comparison
Compare PAHC & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAHC
- BLFS
- Stock Information
- Founded
- PAHC 1946
- BLFS 1987
- Country
- PAHC United States
- BLFS United States
- Employees
- PAHC N/A
- BLFS N/A
- Industry
- PAHC Biotechnology: Pharmaceutical Preparations
- BLFS Medical/Dental Instruments
- Sector
- PAHC Health Care
- BLFS Health Care
- Exchange
- PAHC Nasdaq
- BLFS Nasdaq
- Market Cap
- PAHC 968.3M
- BLFS 1.1B
- IPO Year
- PAHC 2014
- BLFS 1989
- Fundamental
- Price
- PAHC $23.88
- BLFS $21.22
- Analyst Decision
- PAHC Sell
- BLFS Strong Buy
- Analyst Count
- PAHC 4
- BLFS 7
- Target Price
- PAHC $20.00
- BLFS $30.57
- AVG Volume (30 Days)
- PAHC 219.1K
- BLFS 565.5K
- Earning Date
- PAHC 05-07-2025
- BLFS 08-07-2025
- Dividend Yield
- PAHC 2.02%
- BLFS N/A
- EPS Growth
- PAHC 140.17
- BLFS N/A
- EPS
- PAHC 0.78
- BLFS N/A
- Revenue
- PAHC $1,190,682,000.00
- BLFS $87,762,000.00
- Revenue This Year
- PAHC $28.33
- BLFS $21.21
- Revenue Next Year
- PAHC $13.78
- BLFS $17.58
- P/E Ratio
- PAHC $30.48
- BLFS N/A
- Revenue Growth
- PAHC 19.12
- BLFS 34.80
- 52 Week Low
- PAHC $16.16
- BLFS $18.70
- 52 Week High
- PAHC $26.55
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- PAHC 53.14
- BLFS 41.52
- Support Level
- PAHC $23.83
- BLFS $21.76
- Resistance Level
- PAHC $25.15
- BLFS $22.76
- Average True Range (ATR)
- PAHC 0.69
- BLFS 1.14
- MACD
- PAHC -0.19
- BLFS -0.11
- Stochastic Oscillator
- PAHC 44.85
- BLFS 22.41
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.